UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mast Cell Activation Syndrome: Improved Identification by Combined Determinations of Serum Tryptase and 24-Hour Urine 11β-Prostaglandin2α

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2014-11, Vol.2 (6), p.775-778

2014

Volltextzugriff (PDF)

How good are mast cell mediators?

Annals of allergy, asthma, & immunology, 2021-10, Vol.127 (4), p.410-411

Weiler, Catherine R.

2021

Volltextzugriff (PDF)

Mast Cell Activation Syndrome: Tools for Diagnosis and Differential Diagnosis

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2020-02, Vol.8 (2), p.498-506

Weiler, Catherine R.

2020

Volltextzugriff (PDF)

The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2020-09, Vol.8 (8), p.2533-2541

2020

Volltextzugriff (PDF)

Mastocytosis, Quinolones, MRGPRX2, and Anaphylaxis

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2019-07, Vol.7 (6), p.2091-2092

Weiler, Catherine R.

2019

Volltextzugriff (PDF)

Hematologic Malignancies Identified in Patients with Hypereosinophilia and Hypereosinophilic Syndromes

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2015-11, Vol.3 (6), p.920-925

2015

Volltextzugriff (PDF)

Omalizumab and Mast Cell Disorders: Are We There Yet?

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2019-09, Vol.7 (7), p.2396-2397

Weiler, Catherine R.

2019

Volltextzugriff (PDF)

AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management

Journal of allergy and clinical immunology, 2019-10, Vol.144 (4), p.883-896

2019

Volltextzugriff (PDF)

Lack of evidence for intrathecal tryptase synthesis in patients with systemic mastocytosis

Journal of allergy and clinical immunology, 2013-10, Vol.132 (4), p.996-997

2013

Volltextzugriff (PDF)

Mast Cells, Eosinophils and Eosinophilic Esophagitis

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB287-AB287

2014

Volltextzugriff (PDF)

Accurate Diagnosis and Prognosis in Systemic Mastocytosis: The Role of Mutational Analysis

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2020-10, Vol.8 (9), p.3128-3129

2020

Volltextzugriff (PDF)

Anaphylaxis: Advances in the Past 10 Years

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2023-01, Vol.11 (1), p.51-62

2023

Volltextzugriff (PDF)

Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

Journal of Allergy and Clinical Immunology, 2006-04, Vol.117 (4), p.S525-S553

2006

Volltextzugriff (PDF)

Eosinophilic Esophagitis: Allergic Contribution, Testing, and Management

Current gastroenterology reports, 2012-06, Vol.14 (3), p.206-215

2012

Volltextzugriff (PDF)

The Melkersson–Rosenthal syndrome: a retrospective study of biopsied cases

Journal of neurology, 2013, Vol.260 (1), p.138-143

2013

Volltextzugriff (PDF)

Systemic Mastocytosis (SM) and Mast Cell Activation Syndrome (MCAS); How Do They Differ?

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB275-AB275

2018

Volltextzugriff (PDF)

Mast cell sarcoma: clinical management

Immunology and allergy clinics of North America, 2014-05, Vol.34 (2), p.423-432

2014

Volltextzugriff (PDF)

Hypereosinophilic syndrome: endomyocardial biopsy versus echocardiography to diagnose cardiac involvement

Postgraduate medicine, 2017-07, Vol.129 (5), p.517-523

2017

Volltextzugriff (PDF)

Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production

International archives of allergy and immunology, 2008, Vol.147 (4), p.338-343

2008

Volltextzugriff (PDF)

Increased Numbers of Eosinophils, Rather Than Only Etiology, Predict Histologic Changes in Patients With Esophageal Eosinophilia

Clinical gastroenterology and hepatology, 2012-07, Vol.10 (7), p.735-741

2012

Volltextzugriff (PDF)

Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D2 Production

International archives of allergy and immunology, 2008-11, Vol.147 (4), p.338-343

2008

Volltextzugriff (PDF)

Presentation of Untreated Systemic Mastocytosis as Recurrent, Pulseless-Electrical-Activity Cardiac Arrests Resistant to Cardiac Pacemaker

International archives of allergy and immunology, 2014-02, Vol.163 (2), p.130-134

2014

Volltextzugriff (PDF)

Use of pegylated interferon in hypereosinophilic syndrome

Leukemia research, 2012-02, Vol.36 (2), p.192-197

2012

Volltextzugriff (PDF)

Eosinophilic Esophagitis: Is It All Allergies?

Mayo Clinic proceedings, 2007-12, Vol.82 (12), p.1541-1549

2007

Volltextzugriff (PDF)

Systemic mastocytosis in the elderly

American journal of hematology, 2013-05, Vol.88 (5), p.406-408

2013

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(87)
Berichte
(1)

Sprache

Englisch
(88)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mast Cell Activation Syndrome: Improved Identification by Combined Determinations of Serum Tryptase and 24-Hour Urine 11β-Prostaglandin2α

How good are mast cell mediators?

Mast Cell Activation Syndrome: Tools for Diagnosis and Differential Diagnosis

The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome

Mastocytosis, Quinolones, MRGPRX2, and Anaphylaxis

Hematologic Malignancies Identified in Patients with Hypereosinophilia and Hypereosinophilic Syndromes

Omalizumab and Mast Cell Disorders: Are We There Yet?

AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management

Lack of evidence for intrathecal tryptase synthesis in patients with systemic mastocytosis

Mast Cells, Eosinophils and Eosinophilic Esophagitis

Accurate Diagnosis and Prognosis in Systemic Mastocytosis: The Role of Mutational Analysis

Anaphylaxis: Advances in the Past 10 Years

Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

Eosinophilic Esophagitis: Allergic Contribution, Testing, and Management

The Melkersson–Rosenthal syndrome: a retrospective study of biopsied cases

Systemic Mastocytosis (SM) and Mast Cell Activation Syndrome (MCAS); How Do They Differ?

Mast cell sarcoma: clinical management

Hypereosinophilic syndrome: endomyocardial biopsy versus echocardiography to diagnose cardiac involvement

Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production

Increased Numbers of Eosinophils, Rather Than Only Etiology, Predict Histologic Changes in Patients With Esophageal Eosinophilia

Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D2 Production

Presentation of Untreated Systemic Mastocytosis as Recurrent, Pulseless-Electrical-Activity Cardiac Arrests Resistant to Cardiac Pacemaker

Use of pegylated interferon in hypereosinophilic syndrome

Eosinophilic Esophagitis: Is It All Allergies?

Systemic mastocytosis in the elderly

Suchergebnisse filtern